Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.


Discovery & Development

The Argument for Albumin

| Phil Morton

Products are becoming increasingly complex and we need to get better at recognizing the strategies with the best advantages.


Recognizing Friend from Foe

| Werner Cautreels

New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.


Go Forth and Find a Flu Vaccine!

| Stephanie Sutton

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.


Algal Boom

| Andrew Dahl

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?


Dengue Vaccine 101

| Stephanie Sutton

What sparked fears and prompted an anti-vax movement in the Philippines?


Fantastic Vaccines and Where to Find Them: Lessons Learned with Nima Farzan

| Nima Farzan

Public health groups have helped boost interest in the underserved market of specialty vaccines.


Flu Fighters

The industry draws one step closer to creating a universal flu vaccine.

Discovery & Development

An All-in-One Vaccine

| William Aryitey

The solution to multiple drugs co-existing in a syringe may lie with microparticles


The PATH to Success

| Steve Davis

Steve Davis details some of the PATH's success stories in global health.


Taking the Transformative PATH

| Steve Davis

Steve Davis, President and CEO of PATH, and lecturer, Social Innovation, at Stanford University, California, USA.

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine


December Issue of The Medicine Maker